Tyr332
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.9.3
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Tyr332  -  BKR2 (human)

Site Information
SCLNPLVyVIVGKRF   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 451672

In vivo Characterization
Methods used to characterize site in vivo:
2D analysis ( 1 ) , [32P] bio-synthetic labeling ( 1 ) , immunoprecipitation ( 1 ) , mutation of modification site ( 1 ) , phosphopeptide mapping ( 1 )
Relevant cell line - cell type - tissue:

Upstream Regulation
Treatments:
bradykinin ( 1 )

Downstream Regulation
Effects of modification on BKR2:
intracellular localization ( 1 ) , molecular association, regulation ( 1 ) , receptor internalization, altered ( 1 )

References 

1

Kalatskaya I, et al. (2004) Mutation of tyrosine in the conserved NPXXY sequence leads to constitutive phosphorylation and internalization, but not signaling, of the human B2 bradykinin receptor. J Biol Chem 279, 31268-76
15161928   Curated Info